Utilizing A Structured Benefit-Risk Assessment To Evaluate A Combination Of Olanzapine And Samidorphan For The Treatment Of Schizophrenia And Bipolar I Disorder
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要